In a recent article posted on Pharmaceutical Compliance Monitor, Dr. Frank Gozzo, president and CEO of Noverant, discusses the FDA’s move towards a more transparent and collaborative approval process. He explains why this change is being made and how it requires companies within the pharmaceutical industry to maintain robust compliance management systems. To learn more about why…
Request Your Free Trial!
Register to receive your free, personalized Noverant LMS trial today and discover the benefits of a Learning Management System (LMS) built to help any organization make the leap to digital learning management. There is no obligation to purchase.